Skip to content

The Effectiveness of tDCS on Internet Game Addiction

Randomized Double-blind Clinical Trial to Evaluate the Effectiveness of Transcranial Direct Current Stimulation (tDCS) on Internet Game Addiction

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03347643
Enrollment
31
Registered
2017-11-20
Start date
2017-09-22
Completion date
2019-10-08
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction, Internet Gaming Disorder

Keywords

Internet game addiction, Internet gaming disorder, transcranial direct current stimulation, response inhibition, craving, cue reactivity

Brief summary

In this study, the investigators aimed to investigate the effect of transcranial direct current stimulation (tDCS) on clinical status of Internet game addiction. The clinical status of Internet game addiction includes severity of addiction symptom, subjective craving for gaming, response inhibition and cue reactivity. The investigators hypothesized that real stimulation with tDCS on the dorsolateral prefrontal cortex will have higher effectiveness on severity of addiction symptom, subjective craving for gaming, response inhibition and cue reactivity rather than sham stimulation with tDCS.

Interventions

DEVICEtDCS with real stimulation

tDCS is a non-invasive brain stimulation. Real stimulation includes 2mA current for 20 minutes per session. Two sessions a day for 5 consecutive days (Total: 10 sessions) will be applied.

DEVICEtDCS with sham stimulation

Sham stimulation includes 0mA current for 20 minutes per session. Two sessions a day for 5 consecutive days (Total: 10 sessions) will be applied.

Sponsors

National Research Foundation of Korea
CollaboratorOTHER
SMG-SNU Boramae Medical Center
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Patients with internet gaming disorder will be randomly allocated into 1) actual real stimulation with tDCS group, and 2) sham stimulation with tDCS group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Internet gaming disorder based on diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders (DSM)-5.

Exclusion criteria

* History of seizure * History of significant head injury * Mental retardation * Schizophrenia * History of stroke

Design outcomes

Primary

MeasureTime frameDescription
Young Internet Addiction Test (Y-IAT)baselineThe Y-IAT is rated on a five-point scale. Total scores for all 20 items range from 20 to 100.

Secondary

MeasureTime frameDescription
Direction error and successful stop ratio in the Stop signal taskbaseline, 5 weeks, 25 weeksThe stop signal task is a neurocognitive task for assessing response inhibition.
Barratt impulsiveness scale-11baseline, 5 weeks, 25 weeksBarratt impulsiveness scale-11 is a self-report questionnaire consisting of 30 items. Each question has a 4-point scale ranging from 1 (rarely/never) to 4 (almost always/always). This scale scores three subscales: attentional impulsiveness, motor impulsiveness, and nonplanning impulsiveness. The total score ranges from 30 to 120 and higher scores indicate greater impulsivity.
Anti-saccade error rate in the attentional bias taskbaseline, 5 weeks, 25 weeksThe attentional bias task is measured by anti-saccade task using eye-tracking analysis for assessing attentional bias on Internet gaming stimuli.
Late positive potential in the cue reactivity event-related potentialbaseline, 5 weeks, 25 weeksEvent-related potential measures with cue reactivity task
Visual analogue scalebaseline, 1 week, 5 weeks, 25 weeksSubjective craving for Internet gaming ranging from 0 to 10. Higher score represents higher craving for gaming.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026